Page 3 - Guy Meyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Catenae Innovation snap up stake in 'win win' Hyperneph Software collaboration Catenae Innovation Plc's (LON:CTEA) Guy Meyer talks to Proactive London after announcing that it has acquired a 51% interest in Hyperneph Software for £320,000. Hyperneph is a software and application development consultancy, focusing on digital transformation. The rationale for the acquisition is to secure and enhance its ability to deliver innovative software-based solutions. Quick facts: Catenae Innovation Plc Price: 2.4 GBX

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

  The Company's announcement (RNS Number: 9835M) of 27 January 2021 (the "Announcement") misstated the terms of the of Broker Warrants issued to the Company's broker Brandon Hill Capital Limited as part of their remuneration in relation to the Placing. In error, the Announcement stated that Brandon Hill Capital Limited would receive a warrant over 750,000 new ordinary shares in the Company which could be exercised at a price of 3.0p per share at any time up to 3 February 2024. Brandon Hill Capital Limited was entitled to receive a warrant over 2,500,000 new ordinary shares in the Company whi...

    Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that, further to the announcement made by the Company on 16 October 2020, it has renamed its 50/50 Joint Venture Company to Synovate Global Limited ("Synovate") and Synovate has received its first orders.   Synovate is a joint venture between Catenae and BHA-Medical ("BHA") in which Catenae licenses its technology platforms and BHA provides its Covid-19 CE-certified and scientifically validated by the UK Government Near-Patient Healgen Antigen test and its Covid-19 CE-certified Near...